WELL HEALTH TECHNOLOGIES COR (WELL.CA) Stock Fundamental Analysis
Canada - TSX:WELL - CA94947L1022 - Common Stock
4.44 CAD
-0.06 (-1.33%)
We assign a fundamental rating of 3 out of 10 to WELL. WELL was compared to 15 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of WELL have multiple concerns. WELL is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year WELL was profitable.
In the past year WELL has reported a negative cash flow from operations.
In multiple years WELL reported negative net income over the last 5 years.
WELL had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
WELL has a Return On Assets of -2.14%. This is in the lower half of the industry: WELL underperforms 60.00% of its industry peers.
WELL's Return On Equity of -5.12% is in line compared to the rest of the industry. WELL outperforms 46.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WELL has a Gross Margin of 39.97%. This is comparable to the rest of the industry: WELL outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of WELL has grown nicely.
WELL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL does not have a ROIC to compare to the WACC, probably because it is not profitable.
WELL has more shares outstanding than it did 1 year ago.
WELL has more shares outstanding than it did 5 years ago.
The debt/assets ratio for WELL has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.13, we must say that WELL is in the distress zone and has some risk of bankruptcy.
WELL has a Altman-Z score (1.13) which is comparable to the rest of the industry.
A Debt/Equity ratio of 0.67 indicates that WELL is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.67, WELL is doing good in the industry, outperforming 73.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.13 |
ROIC/WACCN/A
WACC8.49%
2.3 Liquidity
A Current Ratio of 0.92 indicates that WELL may have some problems paying its short term obligations.
With a decent Current ratio value of 0.92, WELL is doing good in the industry, outperforming 73.33% of the companies in the same industry.
WELL has a Quick Ratio of 0.92. This is a bad value and indicates that WELL is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL has a better Quick ratio (0.92) than 80.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
WELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 183.33%, which is quite impressive.
The Revenue has grown by 26.20% in the past year. This is a very strong growth!
WELL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.78% yearly.
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.96%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
3.2 Future
Based on estimates for the next years, WELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.57% on average per year.
The Revenue is expected to grow by 14.80% on average over the next years. This is quite good.
EPS Next Y114.58%
EPS Next 2Y60.11%
EPS Next 3Y34.36%
EPS Next 5Y18.57%
Revenue Next Year42.87%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y14.8%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
WELL is valuated quite expensively with a Price/Earnings ratio of 29.60.
73.33% of the companies in the same industry are more expensive than WELL, based on the Price/Earnings ratio.
WELL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.06, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 11.55, which indicates a very decent valuation of WELL.
WELL's Price/Forward Earnings ratio is rather cheap when compared to the industry. WELL is cheaper than 93.33% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 32.73. WELL is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.6 | ||
| Fwd PE | 11.55 |
4.2 Price Multiples
WELL's Enterprise Value to EBITDA is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 18.36 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WELL's earnings are expected to grow with 34.36% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y60.11%
EPS Next 3Y34.36%
5. Dividend
5.1 Amount
No dividends for WELL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL (11/7/2025, 7:00:00 PM)
4.44
-0.06 (-1.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap1.13B
Revenue(TTM)1.21B
Net Income(TTM)-43.25M
Analysts81
Price Target7.82 (76.13%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.35%
Min Revenue beat(2)-3.46%
Max Revenue beat(2)-1.25%
Revenue beat(4)1
Avg Revenue beat(4)-3.93%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)3
Avg Revenue beat(8)-1.49%
Revenue beat(12)5
Avg Revenue beat(12)-0.71%
Revenue beat(16)9
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)0.23%
EPS NQ rev (1m)36.4%
EPS NQ rev (3m)270.79%
EPS NY rev (1m)41.3%
EPS NY rev (3m)46.77%
Revenue NQ rev (1m)-0.66%
Revenue NQ rev (3m)30.95%
Revenue NY rev (1m)-0.48%
Revenue NY rev (3m)0.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.6 | ||
| Fwd PE | 11.55 | ||
| P/S | 0.93 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.34 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.36 |
EPS(TTM)0.15
EY3.38%
EPS(NY)0.38
Fwd EY8.66%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS4.76
BVpS3.33
TBVpS-2.56
PEG (NY)0.26
PEG (5Y)N/A
Graham Number3.35
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.14% | ||
| ROE | -5.12% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.97% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score1
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 6.23 | ||
| Cap/Depr | 27.43% | ||
| Cap/Sales | 2.1% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.92 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.13 |
F-Score1
WACC8.49%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)183.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%104.96%
EPS Next Y114.58%
EPS Next 2Y60.11%
EPS Next 3Y34.36%
EPS Next 5Y18.57%
Revenue 1Y (TTM)26.2%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%44.83%
Revenue Next Year42.87%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y14.8%
EBIT growth 1Y-102.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y46.37%
FCF growth 1Y-170.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-132.25%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES COR / WELL.CA FAQ
What is the ChartMill fundamental rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a fundamental rating of 3 / 10 to WELL.CA.
What is the valuation status of WELL HEALTH TECHNOLOGIES COR (WELL.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to WELL HEALTH TECHNOLOGIES COR (WELL.CA). This can be considered as Fairly Valued.
What is the profitability of WELL stock?
WELL HEALTH TECHNOLOGIES COR (WELL.CA) has a profitability rating of 2 / 10.
What is the valuation of WELL HEALTH TECHNOLOGIES COR based on its PE and PB ratios?
The Price/Earnings (PE) ratio for WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 29.6 and the Price/Book (PB) ratio is 1.34.
How financially healthy is WELL HEALTH TECHNOLOGIES COR?
The financial health rating of WELL HEALTH TECHNOLOGIES COR (WELL.CA) is 2 / 10.